CIK: 0001600135
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SG7 | Sage Therapeutics INC | Stock-Other | 34.97% | -41.20% | — | |
| 2 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 28.13% | — | — | |
| 3 | ZFGNUSD | Zafgen INC | Stock-Other | 14.13% | -10.91% | — | |
| 4 | ✓ | Stock-Other | 9.11% | — | — | ||
| 5 | ✓ | Foundation Medicine INC | Stock-Other | 8.95% | — | — | |
| 6 | ✓ | Eleven Biotherapeutics INC | Stock-Other | 4.70% | -0.33% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | AGIO | Agios Pharmaceuticals INC | +6.2% | — | Unchanged |
| 2 | ✓ | +4% | — | Unchanged | |
| 3 | ZFGNUSD | Zafgen INC | +1.3% | — | Unchanged |
| 4 | ✓ | Eleven Biotherapeutics INC | -1.6% | — | Unchanged |
| 5 | ✓ | Foundation Medicine INC | -2% | — | Unchanged |
| 6 | SG7 | Sage Therapeutics INC | -8% | — | Unchanged |